NewsBenzingaL’abstract di Purple Biotech su IM1240, l’anticorpo tri-specifico di punta della piattaforma CAPTN-3, accettato per una presentazione orale al 38° Simposio EORTC-NCI-AACR L’abstract di Purple Biotech su IM1240, l’anticorpo tri-specifico di punta della piattaforma CAPTN-3, accettato per una presentazione orale al 38° Simposio EORTC-NCI-AACR Benzinga 2026.10.29 13:02 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3